07.13.18
With the recent launch of Zynamite— a patent-pending botanical extract for the sports nutrition and food supplement industry—the company Nektium is poised to meet increased consumer demand for natural ergogenic and mental energy caffeine replacement products.
Zynamite was researched by Nektium´s R&D team over a period of three years. In keeping with Nektium´s evidence-based research philosophy, the product is backed by several preclinical studies and two clinical trials.
A successful research collaboration was established between Nektium and the University of Las Palmas de Gran Canaria (ULPGC) with the university team led by Professor José A. L. Calbet, Head of the Human Performance Lab of the Department of Physical Education and member of the Research Institute of Biomedical and Health Sciences (IUIBS). After a promising pilot study, a formal clinical trial was done to investigate the sports performance activities of Zynamite. The findings from this trial were recently published in the journal Frontiers in Physiology in a paper titled “Mangifera indica L. leaf extract in combination with luteolin or Quercetin enhances VO2peak and peak power output and preserves skeletal muscle function during ischemia-reperfusion in humans.”
Researchers examined the effect of Mangifera indica L. leaf extract (MLE) rich in mangiferin (Zynamite) administered with either quercetin (Q) and tiger nut extract (TNE), or with luteolin (Lut) on sprint performance and recovery from ischemia-reperfusion. Thirty young volunteers were randomly assigned to three treatments (A: placebo (500 mg of maltodextrin/day); B: 140 mg of MLE (60% mangiferin) and 50 mg of Lut/day; or C: 140 mg of MLE, 600 mg of Q and 350 mg of TNE/day) 48 hours before exercise. After extensive physical exertion among participants, the scientists found MLE extract rich in mangiferin combined with either quercetin and tiger nut extract or luteolin exerted a remarkable ergogenic effect, increased muscle power in fatigued subjects, and enhanced peak VO2 and brain oxygenation in women during prolonged sprinting. Importantly, the combination of MLE+Q+TNE improved skeletal muscle contractile function during ischemia/reperfusion.
The full scientific paper is available at: https://frontiersin.org/articles/10.3389/fphys.2018.00740/full
Zynamite was researched by Nektium´s R&D team over a period of three years. In keeping with Nektium´s evidence-based research philosophy, the product is backed by several preclinical studies and two clinical trials.
A successful research collaboration was established between Nektium and the University of Las Palmas de Gran Canaria (ULPGC) with the university team led by Professor José A. L. Calbet, Head of the Human Performance Lab of the Department of Physical Education and member of the Research Institute of Biomedical and Health Sciences (IUIBS). After a promising pilot study, a formal clinical trial was done to investigate the sports performance activities of Zynamite. The findings from this trial were recently published in the journal Frontiers in Physiology in a paper titled “Mangifera indica L. leaf extract in combination with luteolin or Quercetin enhances VO2peak and peak power output and preserves skeletal muscle function during ischemia-reperfusion in humans.”
Researchers examined the effect of Mangifera indica L. leaf extract (MLE) rich in mangiferin (Zynamite) administered with either quercetin (Q) and tiger nut extract (TNE), or with luteolin (Lut) on sprint performance and recovery from ischemia-reperfusion. Thirty young volunteers were randomly assigned to three treatments (A: placebo (500 mg of maltodextrin/day); B: 140 mg of MLE (60% mangiferin) and 50 mg of Lut/day; or C: 140 mg of MLE, 600 mg of Q and 350 mg of TNE/day) 48 hours before exercise. After extensive physical exertion among participants, the scientists found MLE extract rich in mangiferin combined with either quercetin and tiger nut extract or luteolin exerted a remarkable ergogenic effect, increased muscle power in fatigued subjects, and enhanced peak VO2 and brain oxygenation in women during prolonged sprinting. Importantly, the combination of MLE+Q+TNE improved skeletal muscle contractile function during ischemia/reperfusion.
The full scientific paper is available at: https://frontiersin.org/articles/10.3389/fphys.2018.00740/full